|
Volumn 12, Issue 4, 2006, Pages 337-338
|
Successful infliximab therapy for oral Crohn's disease [4]
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
C REACTIVE PROTEIN;
INFLIXIMAB;
ADULT;
CASE REPORT;
CROHN DISEASE;
DRUG EFFICACY;
GASTROINTESTINAL SYMPTOM;
HIGH RISK PATIENT;
HUMAN;
INFLAMMATORY CELL;
LETTER;
MALE;
MOUTH LESION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADULT;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
FOLLOW-UP STUDIES;
GASTROINTESTINAL AGENTS;
HUMANS;
MALE;
MOUTH MUCOSA;
SEVERITY OF ILLNESS INDEX;
|
EID: 33646764550
PISSN: 10780998
EISSN: 15364844
Source Type: Journal
DOI: 10.1097/01.MIB.0000215096.51943.82 Document Type: Letter |
Times cited : (15)
|
References (9)
|